Tue, February 12, 2013
Mon, February 11, 2013

Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $71 on, Feb 12th, 2013

Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $56 to $71 on, Feb 12th, 2013.

Michelle has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michelle


  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $54 on, Tuesday, November 6th, 2012